Skip to main content
. 2012 Oct 17;2012(10):CD004398. doi: 10.1002/14651858.CD004398.pub3

Austin 2004A.

Methods Study design: ITS
Participants Physicians;
Clinical specialty: Not clear;
Level of training: Fully trained;
Setting/Country: Not clear/Canada
Interventions The PEM was the Women’s Health Initiative (WHI) trial, published on July 17, 2002, which concluded that overall health risks exceeded benefits from use of combined estrogen plus progestin among healthy postmenopausal women.
Outcomes 2 process outcomes (prescribing):
  1. the total number of claims for clonidine in Ontario for person of 65 years of age and older (use of clonidine for women) and the

  2. total number of claims for clonidine in Ontario for person of 65 years of age and older (use of clonidine for men).

Notes
Risk of bias
Bias Authors' judgement Support for judgement
Intervention independent of other changes ‐ ITS Low risk Quote, pg. 193: "our study demonstrated a significant increase in incident clonidine use exceeding secular trends among elderly postmenopausal women"
Shape of Intervention effect pre‐specified ‐ ITS High risk Quote, pg. 193: "as women abandoned ERT, some may have initiated treatment with medications such as clonidine, for the treatment of menopausal hot flashes. There are limitations of our study. First, we were unable to determine the exact reason for initiating clonidine. Although clonidine is classified as an antihypertensive medication, it is not commonly used for hypertension"
COMMENT: a rational explanation for the shape of intervention effect was not provided by the authors
Intervention unlikely to affect data collection ‐ ITS Low risk Quote, pg. 191: "Retrospective, population‐based administrative database design"
COMMENT: the intervention itself is unlikely to affect data collection
Blinding of outcome assessors (detection bias) ‐ ITS 
 All outcomes Low risk The outcome was objective
Incomplete outcome data (attrition bias) ‐ ITS 
 All outcomes Low risk Quote, pg. 192: "we studied incident claims for clonidine to Ontario's universal Drug Benefit program for seniors (ODB), which tracks medication use by all 1.3 million residents of Ontario 65 years of age and older"  
COMMENT: data is collected pre‐ and post‐intervention from same province wide data base
Selective reporting (reporting bias) ‐ ITS Low risk  All relevant outcomes in the methods section were reported in the results section
Other bias ‐ ITS Low risk There was no evidence of other risks of bias